Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Oct 26, 2020

SELL
$71.87 - $131.03 $143,740 - $262,060
-2,000 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$79.55 - $124.22 $159,100 - $248,440
2,000 New
2,000 $55,000
Q2 2018

Jul 09, 2018

SELL
$76.01 - $99.03 $152,020 - $198,060
-2,000 Closed
0 $0
Q1 2018

May 01, 2018

BUY
$77.67 - $92.63 $155,340 - $185,260
2,000 New
2,000 $0

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.